13G Filing: Kerrisdale Capital and Adamas Pharmaceuticals Inc (ADMS)

Page 2 of 7 – SEC Filing


CUSIP No. 00548A106 13G
  1

NAME OF
REPORTING PERSONS

Kerrisdale Partners Master Fund Ltd

  2

CHECK THE APPROPRIATE BOX IF A MEMBER
OF A GROUP*

(a)  ☐        (b)  ☐

  3

SEC USE ONLY

  4

CITIZENSHIP OR PLACE OF
ORGANIZATION

Cayman Islands

  5

SOLE VOTING POWER

1,473,247

  6

SHARED VOTING POWER

0

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

  7

SOLE DISPOSITIVE POWER

1,473,247

  8

SHARED DISPOSITIVE POWER

0

  9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON

1,473,247

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

11

PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

6.5%

12

TYPE OF REPORTING PERSON*

CO

* SEE INSTRUCTIONS BEFORE FILLING OUT

Follow Adamas Pharmaceuticals Inc (NASDAQ:ADMS)